The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia

Leukemia

Volumn 11, Issue 12, 1997, Pages 2039-2044

  Koller, C A ^a,b   Kantarjian, H M ^a,b   Thomas, D ^a,b   O'Brien, S ^a,b   Rios, M B ^a,b   Kornblau, S ^a,b   Murphy, S ^a,b   Keating, M ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Acute lymphoblastic leukemia; Reinduction regimens; Remission; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FOLINATE CALCIUM; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEVER; GRANULOCYTE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALVAGE THERAPY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031438576     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400861     Document Type: Article

References (8)

1. Rivera GK, Mauer AM. Controversies in the management of childhood acute lymphoblastic leukemia: treatment intensification, CNS leukemia, and prognostic factors. Semin Oncol 1987; 24: 12-26.
2. Clavell LA, Gelker RD, Cohen HJ, Hitchcock BS, Cassady JR, Tarbell NJ, Blattner SR, Tantravahi R, Leavitt P, Sallan SE. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. New Engl J Med 1986; 315: 657-663.
3. Cortes JE, Kantarjian HM. Acute lymphoblastic leukemia: a comprehensive review with emphasis on biology and therapy. Cancer 1995; 76: 2393-2417.
4. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood 1995; 85: 1151-1168.
5. Kantarjian HM. Adult acute lymphocytic leukemia: critical review of current knowledge. Am J Med 1994; 97: 176-184.
6. Welborn JL. Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults. Am J Hematol 1994; 45: 341-344.
7. Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G, Pui CH, Fairclough D, Berard CW. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (Slg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986; 4: 1732-1739.
8. Kantarjian H, O'Brien S, Beran M, Keating M, Koller C, Robertson L, Andreeff M, Murphy S, Freireich E. Update of the hyper-CVAD program in newly diagnosed adult acute lymphocytic leukemia (ALL). Blood 1995; 86: 173a.